NCT05104944View on ClinicalTrials.gov

Defining Outcome Measures for Acute Charcot Neuroarthropathy in Diabetes and Their Use in Assessing Clinical Management

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 20, 2017

Primary Completion Date

November 30, 2019

Study Completion Date

May 4, 2021

Conditions
Diabetes
Interventions
RADIATION

Serial MRIs

Serial use of MRI at 3, 6, 9 and 12 months to identify disease resolution and thus discontinuation of immobilisation plus standard care.

Trial Locations (1)

NR4 7UY

Norfolk & Norwich University Hospital, Norwich

All Listed Sponsors
collaborator

University of East Anglia

OTHER

lead

Norfolk and Norwich University Hospitals NHS Foundation Trust

OTHER

NCT05104944 - Defining Outcome Measures for Acute Charcot Neuroarthropathy in Diabetes and Their Use in Assessing Clinical Management | Biotech Hunter | Biotech Hunter